I.. Introduction {#sec1}
================

Artificial intelligence (AI) grows fast with the improvement of technology and the availability of various kinds of big data. Machine learning, an AI of the computational statistics, has been introduced in clinical medicine which could provide accurate diagnosis of disease and prediction of the risk [@ref1]--[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]. For example, [@ref12] utilizes the random survival forest technique identifying the top-20 risk factors of cardiovascular events and the performance is superior to the traditional risk calculators. In the modern era, using machine learning techniques has become an efficient and reliable tool for clinical practice by physicians globally.

Left ventricular hypertrophy (LVH), which is clinically considered as a sign of end-organ damage related to long-term hypertension, has been associated with heart failure and cardiovascular disease events among middle and old-aged individuals [@ref13], [@ref14]. In contrast, the prevalence of LVH in young adults is low, accounting for approximately 5% [@ref15], and the phenotypes are usually caused by physiologic adaptions to intense physical training [@ref16] and congenital hypertrophic cardiomyopathy [@ref17]. A prior population research also shows that the presence of LVH at young ages is associated with higher risk of incident cardiovascular disease events [@ref18]. The 12-lead surface electrocardiography (ECG) is the currently most used tool for screening the presence of LVH in the general population [@ref19]. Several ECG-based criteria such as the Cornell and Sokolow-Lyon formulas have been proposed for more than 30 years [@ref20], [@ref21]; however, the performance of the ECG-based criteria for LVH consistently yields high specificity (\>95%) but low sensitivity (20%-30%). Over the past 5 years, a few population studies were presented by machine learning and deep learning for the ECG characteristics to detect presence of LVH [@ref1]--[@ref2][@ref3]. For hypertrophic cardiomyopathy (HCM), one of the most common pathological LVH, Rahman *et al.* firstly used the random forest and the support vector machine (SVM) techniques, and 5-fold cross validations, for hundreds of ECG characteristics training, where showed excellent results regarding the sensitivity, specificity and precision up to 90% in a hospital-based population study [@ref2]. Subsequently, Tison *et al.* used the deep learning of convolutional neural network for numerous ECG parameters to identify HCM, consistently showing excellent results in a hospital-based population study [@ref3]. However, the sensitivity using the specific ECG criteria for HCM has approached up to 90% [@ref22], [@ref23]. By contrast, a community-based population study using machine learning for the ECG to screen any unspecific LVH was proposed by Sparapani *et al.* [@ref1]. Despite this study utilized the tree-based, Bayesian nonparametric machine learning technique for a number of ECG characteristics alone, the sensitivity for detecting any unspecific LVH phenotype in a general population of middle and old aged individuals is increased up to 29.0%, merely a little improvement compared with the other ECG criteria for LVH [@ref1]. Accordingly, computerized training of the ECG alone might not be adequate in screening for unspecific LVH in the general population level.

In this paper, we aim to develop a clinically accessible ECG-based system which uses a large sample of the military young personnel taking age, anthropometric data and several ECG characteristics into account for machine learning by the method of SVM to predict the presence of unspecific LVH as shown in [Fig. 1](#fig1){ref-type="fig"}. The rest of this paper is organized as follows. The materials are presented in [Section II](#sec2){ref-type="sec"}. In [Section III](#sec3){ref-type="sec"}, the proposed algorithm regarding the ECG system for unspecific LVH detection is described in detail. [Section IV](#sec4){ref-type="sec"} displays the experimental results. [Section V](#sec5){ref-type="sec"} concludes this paper. FIGURE 1.Schematic diagram of proposed system.

II.. Data Collection and Features Selection {#sec2}
===========================================

A.. Data Collection {#sec2a}
-------------------

This study uses a population of 2,196 military males aged 17--45 years from the ancillary cardiorespiratory fitness and hospitalization events in armed forces (CHIEF) substudy performed in the Hualien Armed Forces General Hospital in Hualien city, Taiwan, R.O.C. Each participant received an ECG and an echocardiography at the same clinic visit in a health examination prior to the annual exercise tests for the military rank promotions and awards. The study design has been described in detail previously [@ref24]--[@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33]. The raw data of 12-lead ECG parameters are interpreted by the software products of two ECG manufacturers: one is the CARDIOVIT MS-2015 (Schiller AG, Baar, Switzerland), and another one is the TC70 CARDIOGRAPH (Philips, Amsterdam, Netherlands). The transthoracic echocardiography is performed via the IE33 (Philips, Amsterdam, Netherlands). All the echocardiography and ECG procedures are implemented by the same technician who has been certificated with plenty of experiences for longer than 20 years. The 28 ECG characteristics adopted in the proposed method include heart rate, the durations of P wave, PR interval, QRS interval, QT interval and QTc interval in Lead II, and the axes of P, QRS, and T waves in Lead II, and the voltages of R waves in all Limb Leads I, II, III, aVR, aVL, aVF and S wave in Lead aVL, and the voltages of R and S waves in all precordial Leads V1-V6, where the voltage of 1 mV indicates 10 mm. In addition, a population of 203 military females aged 17--42 from the ancillary CHIEF substudy is utilized as an additional test set using the male model of machine learning by age, anthropometric data and ECG parameters. The comparison methods are the Sokolow-Lyon voltage criterion for LVH [@ref20] and the Cornell voltage criteria for males and females [@ref21], which are revealed in [Table 1](#table1){ref-type="table"}, respectively.TABLE 1Electrocardiographic and Echocardiographic Criteria for Left Ventricular HypertrophyCriteriaSex-specificDescriptionElectrocardiographicSokolow-Lyon voltageBoth Sexes(S-V1 or S-V2+ R-V5 or R-V6) ≥ 35 mmCornell voltageMale AdultsR-aVL+S-V3 ≥ 28 mmFemale AdultsR-aVL+S-V3 ≥ 20 mmEchocardiographicCARDIA-basedYoung Male AdultsLVM/BSA ≥ 116 gram/meter^2^ or LVM/height^2.7^≥ 49 gram/meter^2.7^CHIEF-basedYoung Female AdultsLVM/BSA ≥ 88 gram/meter^2^ or LVM/ height^2.7^ ≥ 41 gram/meter^2.7^Abbreviations: CARDIA, coronary artery risk development in young adults; CHIEF, cardiorespiratory fitness and hospitalization events in armed forces

The diagnosis of LVH is based on the recommendations of the American Society of Echocardiography [@ref34]. Quantification of left ventricular internal dimension (LVIDd) and left ventricular wall thickness including interventricular septum (IVSd) and left ventricular posterior wall (LVPWd) is measured by M-mode and 2-dimensional methods at the mitral valve tips and at the onset of the QRS complex in ECG of end diastole in echocardiographic parasternal long axis view. Left ventricular mass (LVM) is calculated on the basis of the corrected echocardiographic formula proposed by Devereux *et al.* [@ref35] as shown in [(1)](#deqn1){ref-type="disp-formula"}.$$\documentclass[12pt]{minimal}
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\end{document}$ percentile of the military females in the CHIEF study and the results of a prior study for Southeastern Asia young females [@ref38]. The sex-specific echocardiographic criteria for LVH are listed in [Table 1](#table1){ref-type="table"}. To develop the proposed machine learning method, the data are partitioned into 80% for cross validation and 20% for test for the male samples. The study protocol was approved by the Institutional Review Broad of Mennonite Christian Hospital (No. 16-05-008) in Hualien City, Taiwan.

B.. Pre-Test for Input Features {#sec2b}
-------------------------------

To select the proper features, at initial stage, we stepwise add several biological parameters on the 28 ECG parameters, as input features for SVM machine learning to determine the most clinically efficient system. These biological parameters include age, body height, body weight, body mass index (BMI), waist circumference, systolic blood pressure (SBP), diastolic blood pressure (DBP) and body surface area (BSA). The preliminary performances of additional biological parameters and adopted 28 ECG parameters are listed in [Table 2](#table2){ref-type="table"}. For the stepwise pre-test of input features, we only take training set and test set without cross validation for SVM model to compare the results of various ECG-based combinations. As shown in [Table 2](#table2){ref-type="table"}, when more input parameters are trained, there are larger area under curves (AUCs) of the Receiver Operating Characteristic (ROC) curves and Precision-Recall (PR) curves in the test set. A significant improvement in AUCs of the ROC and PR curves is observed when using age, body height, body weight with the 28 ECG parameters as inputs to relate to the output of LVH. Additional inputs of BMI, waist circumference, BSA, SBP and DBP are neutral or merely increase a little in performance. Thus, the 31 features including age, body height, body weight, and the 28 ECG parameters are determined as the input features of our machine learning model. The average values in each parameter of the participants are revealed in [Table 3](#table3){ref-type="table"}. The label of LVH is by the echocardiographic LVM/BSA ≥ 116 gram/meter^2^ or LVM/height^2.7^ ≥ 49 gram/meter^2.7^ for young males. As shown in [Table 3](#table3){ref-type="table"}, the characteristics in those with and those without LVH are continuous data which are expressed as mean ± standard deviation and compared by two samples t-test. A p-value \< 0.05 is considered significant. Notably, older age, lower body height and greater body weight are observed in those with echocardiographic LVH.TABLE 2Preliminary Performance of Additional Biological Parameters and Adopted 28 ECG ParametersECG (28)✔✔✔✔✔✔✔Age--✔✔✔✔✔✔Height and Weight----✔✔✔✔✔BMI------✔✔✔✔Waist Circumference--------✔--✔SBP and DBP----------✔✔BSA------------✔Number of input features28293132333436ROC AUC0.7650.7720.8550.8580.8600.8570.866PR AUC0.2150.2140.3030.3110.3140.3220.339TABLE 3Characteristics of Study Participants (Males)FeaturesTotal N=2196Non-LVH N=2046LVH N=150p-valueAge (years)25.93± 6.7725.68± 6.6729.41± 7.18\< 0.001Height (cm)172.01± 5.92172.19± 5.89169.55± 5.68\< 0.001Weight (kg)72.47± 12.0371.86± 11.7380.73± 13.06\< 0.001Heart rate (bpm)67.38± 11.8367.47± 11.6966.03± 13.530.206P-II(ms)105.85± 15.26105.80± 15.17106.57± 16.490.551PR-II(ms)157.91± 21.02157.40± 20.97164.91± 20.45\< 0.001QRS-II(ms)97.26± 10.7597.11± 10.7099.28± 11.240.017QT-II(ms)372.21± 29.64371.21± 29.28385.82± 31.24\< 0.001QTc-II(ms)390.14± 24.56389.71± 24.30396.01± 27.340.007P axis-II(degree)44.78± 27.2145.41± 27.2036.09± 25.99\< 0.001QRS axis-II(degree)65.22± 32.2365.92± 31.9655.71± 34.34\< 0.001T axis-II(degree)35.87± 21.3736.52± 21.1427.03± 22.65\< 0.001R-I(mm)5.81± 3.005.65± 2.907.99± 3.43\< 0.001R-II(mm)12.86± 4.9312.97± 4.9111.35± 5.02\< 0.001R-III(mm)8.53± 5.838.71± 5.866.04± 4.81\< 0.001R-aVR(mm)1.62± 2.311.58± 2.262.14± 2.790.019R-aVL(mm)2.34± 2.232.24± 2.103.73± 3.24\< 0.001S-aVL(mm)2.21± 2.982.28± 3.021.31± 2.23\< 0.001R-aVF(mm)10.50± 5.3410.67± 5.338.20± 4.80\< 0.001R-V1(mm)3.54± 2.283.55± 2.273.37± 2.450.347S-V1(mm)10.25± 5.3010.27± 5.259.96± 6.010.542R-V2(mm)8.58± 4.248.55± 4.199.08± 4.900.199S-V2(mm)16.01± 6.8916.08± 6.9215.04± 6.520.075R-V3(mm)13.26± 6.2313.20± 6.2214.02± 6.260.119S-V3(mm)8.45± 5.348.39± 5.309.29± 5.800.045R-V4(mm)19.73± 6.8419.80± 6.8718.78± 6.440.076S-V4(mm)5.15± 4.105.10± 4.095.82± 4.280.039R-V5(mm)19.86± 5.8619.85± 5.8319.95± 6.310.848S-V5(mm)3.17± 2.933.14± 2.913.49± 3.180.168R-V6(mm)16.35± 5.0816.32± 5.0616.84± 5.320.223S-V6(mm)1.86± 1.991.85± 1.981.92± 2.200.721

III.. Proposed Method {#sec3}
=====================

According to the preliminary pre-test outcomes, the 31 input factors for machine learning are age, body height, body weight and the adopted 28 ECG parameters. This paper uses the SVM for predicting the presence of LVH among young adults. The reason for selecting SVM as the model is due to the advantages of SVM classifier which are effective in high dimensional spaces and memory efficient, and could provide successful discriminative models in many fields [@ref2], [@ref39]--[@ref40][@ref41]. In addition, the training time and running time of SVM are extremely short. Therefore, we utilize the SVM machine learning technique which can be feasible in an ECG equipment to achieve practical application. The flowchart of the proposed method is illustrated in [Fig.2](#fig2){ref-type="fig"}. FIGURE 2.Flowchart of the proposed method.

A.. Data Normalization {#sec3a}
----------------------

Firstly, we use the normalization of Min-Max scaling [@ref42], [@ref43] to individually normalize the original data of 31 input features into the interval between 0\~1 for solving the problem of different dynamic ranges of various input features. Min-Max normalization performs a linear transformation on the original data. Each of the actual data $\documentclass[12pt]{minimal}
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B.. Cross Validation {#sec3b}
--------------------

The data of 2,196 military males are segmented into a total training and validation set and a test set with 4:1 ratio. The total training and validation set is partitioned into four equal size groups. Among the four groups, one group is treated as the validation set for validating the model, and the remaining three groups are taken as the training set. Each of the four groups is used once as the validation set. The proportions of non-LVH and LVH cases are similar across each group. The cross validation process is then repeated four times. Four AUCs of PR curves from the four folds are averaged as a single performance of the results. By using a 4-fold cross validation, a better generalization assessment of the performance for training can be obtained.

C.. Application of Smote {#sec3c}
------------------------

The data numbers illustrated by four folds are described in detail in [Table 4](#table4){ref-type="table"}. Our datasets are predominately composed of non-LVH cases with only a small percentage of LVH cases since the prevalence of LVH in young adults is approximately 5%. For example, in [Table 4](#table4){ref-type="table"}, the 1st cross validation, the numbers of the training set and validation set are 1,317 (Non-LVH: 1,225, LVH: 92) and 439 (Non-LVH: 408, LVH: 31), respectively. This imbalance in sample sizes between the Non-LVH and LVH cases is obvious. The solution for this issue is to increase LVH cases in pre-processing by applying the synthetic minority over-sampling technique (SMOTE) [@ref44]. The main idea of SMOTE is to create new minority class samples by choosing a near minority class neighbor randomly and interpolating as described as follows. Firstly, for each minority class sample $\documentclass[12pt]{minimal}
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\end{document}$}. The process of applying SMOTE can be treated as interpolating between two LVH samples in the viewpoint of geometry. The decision space for the LVH samples is expanded. Thus, it allows the SVM method to have a higher prediction performance on unknown LVH samples. The SMOTE is used in the process of 4-fold cross validation. The training data of the LVH group are pre-processed and augmented by SMOTE to be the same numbers with those of the Non-LVH group as 1,225, 1,230, 1,229 and 1,215, respectively, for the four folds as shown in [Table 4](#table4){ref-type="table"}. We also compare the performances of the test set for the proposed model with and without using SMOTE.TABLE 4Data Numbers in the Training and Validation SetFoldDataNon-LVHLVHTotal1stTraining Set1225921317Pre-processed by SMOTE122512252450Validation Set408314392ndTraining Set1230871317Pre-processed by SMOTE123012302460Validation Set403364393rdTraining Set1229881317Pre-processed by SMOTE122912292458Validation Set404354394thTraining Set12151021317Pre-processed by SMOTE121512152430Validation Set41821439

D.. Machine Learning Model {#sec3d}
--------------------------

Our proposed method utilizes SVM [@ref45]--[@ref46][@ref47][@ref48] as a binary classifier for machine learning. In our method, a 31-dimensional vector represents a data point and we employ the linear kernel (Linear SVM) to separate such points by a 30-dimesional hyperplane. Maximum-margin is constructed by SVM so that the distance from the hyperplane to the nearest subset of the training data points (support vectors) of Non-LVH or LVH class is maximized. The soft-margin SVM is adopted in our method. Soft-margin SVM allows the wide decision margin and some outliers are inside or on the wrong side of the margin.
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After selecting the optimized hyperparameter, the SVM training model will be determined by the data in the total training and validation set. As shown in [Table 5](#table5){ref-type="table"}, the data of total training and validation set for the LVH group are pre-processed by SMOTE, and the number is increased to 1,633.TABLE 5Data Numbers of Total DataDataNon-LVHLVHTotalTotal Training and Validation Set16331231756Pre-processed by SMOTE163316333266Test Set41327440Total Data20461502196

IV.. Results and Discussion {#sec4}
===========================

Our proposed method is implemented using the software scikit learn v0.20.2 with Python programming language [@ref49]. In addition, the optimal weight vector $\documentclass[12pt]{minimal}
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A.. Performance Measurement {#sec4a}
---------------------------

The specificity 70-75% is the criterion to decide the most appropriate test cut-off probability [@ref50] for our SVM method. The performance is assessed by several standard measurements including accuracy, specificity, sensitivity (recall), precision, F~1~ score, the AUC of the ROC curve and the AUC of the PR curve [@ref51], [@ref52].

The definitions of accuracy, specificity, sensitivity and precision are calculated by true positive (TP), true negative (TN), false positive (FP), and false negative (FN) as denoted in [(5)](#deqn5-deqn9){ref-type="disp-formula"} - [(8)](#deqn5-deqn9){ref-type="disp-formula"}. The F~1~ score, which is the harmonic average of the precision and recall, is described in [(9)](#deqn5-deqn9){ref-type="disp-formula"}.$$\documentclass[12pt]{minimal}
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B.. Results {#sec4b}
-----------

The results of the 4-fold cross validation for the validation set with the optimized hyperparameter are shown in [Table 6](#table6){ref-type="table"}. The prevalence of LVH in the validation set is range from 4.8% to 8.2% as shown in [Table 6](#table6){ref-type="table"}. Average accuracy, specificity, sensitivity, precision and F~1~ score are 73.3%, 72.9%, 78.8%, 18.3% and 29.3%, respectively. The ROC and PR curves for the four folds are compared in [Fig. 3](#fig3){ref-type="fig"}. The average AUC of the ROC curve is 0.828 and the average AUC of the PR curve is 0.289. [Table 7](#table7){ref-type="table"} shows the prediction results of the total training and validation set, test set and total data. In the total training and validation set, the SMOTE is applied for the LVH group to increase the prevalence rate to 50%. Thus, the precision, F~1~ score and AUC of PR curves are much better than the other two datasets. In the test set and total data, the prevalence of LVH is generally distributed around 6-7% in the population of young adults. The results of the test set for the model with SMOTE regarding the accuracy, specificity, sensitivity, precision and F~1~ score are 76.1%, 75.1%, 92.6%, 19.5% and 32.2%, respectively, which are in line with the results of the total data for the model with SMOTE, and better than 74.6%, 73.9%, 85.2%, 17.6%, and 29.2%, respectively, for the model without using SMOTE. The ROC and PR curves for various datasets are compared in [Fig. 4](#fig4){ref-type="fig"}. The AUC values for the three datasets are similar in ROC curves. The AUC values of ROC and PR curves of the proposed method with SMOTE for test set are 0.871 and 0.272, respectively, and larger than 0.841 and 0.259, respectively, for the model without using SMOTE.TABLE 6Data Numbers and Performances for the 4-Fold Cross ValidationValidation set 1st foldValidation set 2nd foldValidation set 3rd foldValidation set 4th foldAverageNon-LVH Group408403404418--LVH Group31363521--Total439439439439--Prevalence Rate7.1%8.2%8.0%4.8%--Accuracy67.2%77.9%75.9%72.0%73.3%Specificity66.4%78.2%75.7%71.3%72.9%Sensitivity77.4%75.0%77.1%85.7%78.8%Precision14.9%23.5%21.6%13.0%18.3%F~1~-score25.0%35.8%33.7%22.6%29.3%ROC AUC0.8040.8050.8360.8650.828PR AUC0.2840.3120.3300.2280.289True Negative271315306298--False Negative7983--False Positive1378898120--True Positive24272718--TABLE 7Predicted Results of the Proposed Method for Various DatasetsTotal Training and validation set (SMOTE)Test setTotal dataNon-LVH Group16334132046LVH Group163327150Total32664402196Prevalence Rate50.0%6.1%6.8%Accuracy81.2%76.1%74.2%Specificity72.8%75.1%73.3%Sensitivity89.6%92.6%86.7%Precision76.7%19.5%19.2%F~1~-score82.6%32.2%31.4%ROC AUC0.8780.8710.864PR AUC0.8360.2720.308True Negative11893101499False Negative170220False Positive444103547True Positive146325130 FIGURE 3.ROC and PR curves for the 4-fold cross validation. FIGURE 4.ROC and PR curves of the proposed method for various datasets.

Our proposed SVM machine learning method is also compared with the Sokolow-Lyon voltage and Cornell voltage criteria for LVH as shown in [Table 8](#table8){ref-type="table"}. All data of the 2,196 military males are tested in the model. With the specificity of 73.3%, intended to be set between 70-75%, our SVM technique provides much better sensitivity 86.7% compared to 3.3% and 52.7% regarding the Cornell and Sokolow-Lyon voltage criteria, respectively. The ROC and PR curves for the three approaches are shown in [Fig. 5](#fig5){ref-type="fig"}. It is obvious that the proposed method is much superior to the other two traditional ECG voltage criteria.TABLE 8Performance Comparison of Proposed Method and Traditional ECG Voltage CriteriaSVMCornell voltageSokolow-Lyon voltageCut-off Value0.42228 mm35 mmAccuracy74.2%93.0%43.8%Specificity73.3%99.6%43.2%Sensitivity86.7%3.3%52.7%Precision19.2%35.7%6.4%F~1~-score31.4%6.0%11.4%ROC AUC0.8640.6050.470PR AUC0.3080.1090.077True Negative14992037883False Negative2014571False Positive54791163True Positive130579 FIGURE 5.ROC and PR curves of the proposed method and traditional ECG voltage criteria.

In addition, we also test the CHIEF military female subcohort data with the label of echocardiographic LVH by the definitions of LVM/BSA ≥ 88 gram/meter^2^ or LVM/height^2.7^ ≥ 41 gram/meter^2.7^ for young females using the proposed SVM model trained by the military young males. The baseline data with an average for each adopted biological and ECG features of the female participants with and without echocardiographic LVH are revealed in [Table 9](#table9){ref-type="table"}. It is contrary to the findings of the male participants that there are no significant differences in the adopted biological parameters including age, body height and body weight, and there are only two significant differences in the ECG characteristics including the amplitudes of R waves in chest Leads V1 and V3. In addition, the results of the female test set with regard to the accuracy, specificity, sensitivity, precision and F~1~ score are 76.4%, 76.3%, 76.9%, 18.2% and 29.4%, respectively, and shown in detail in [Table 10](#table10){ref-type="table"}. Compared to the conventional Sokolow-Lyon voltage and Cornell voltage criteria specifically for females [@ref21], the proposed SVM method can provide superior performance evaluated by F~1~ score, and the AUCs of the ROC and PR curves. The ROC and PR curves obtained from the female's test data are shown in [Fig. 6](#fig6){ref-type="fig"}.TABLE 9Characteristics of Study Participants (Females)FeaturesTotal N=203Non-LVH N=190LVH N=13p-valueAge (years)25.42± 5.3825.47± 5.3124.69± 6.560.6162Height (cm)160.55± 4.81160.63± 4.75159.35± 5.720.3570Weight (kg)58.90± 9.2458.55± 8.8364.00± 13.340.1711Heart rate (bpm)68.40± 11.7268.23± 11.2471.00± 17.770.5884P-II(ms)100.07± 15.9999.90± 15.60102.54± 21.480.5661PR-II(ms)148.78± 23.52149.41± 23.63139.62± 20.530.1470QRS-II(ms)89.93± 12.1089.55± 11.2395.46± 21.000.3338QT-II(ms)383.96± 34.32383.16± 32.74395.54± 52.760.4193QTc-II(ms)410.01± 29.14408.98± 27.24425.08± 48.410.2576P axis-II(degree)42.16± 28.3342.83± 28.2232.31± 29.160.1957QRS axis-II(degree)71.02± 31.7671.65± 30.8561.92± 43.470.2866T axis-II(degree)33.94± 20.8234.18± 20.0630.31± 30.800.6621R-I(mm)4.19± 2.164.11± 2.085.36± 3.020.1647R-II(mm)11.38± 3.7511.32± 3.7012.22± 4.480.4014R-III(mm)8.34± 4.618.36± 4.578.07± 5.370.8273R-aVR(mm)0.90± 1.170.93± 1.180.57± 0.830.2879R-aVL(mm)1.46± 1.181.42± 1.151.93± 1.470.1330S-aVL(mm)2.69± 2.802.72± 2.812.38± 2.700.6813R-aVF(mm)9.83± 3.929.81± 3.9210.12± 4.030.7816R-V1(mm)2.75± 1.602.67± 1.533.92± 2.100.0059S-V1(mm)7.03± 3.526.91± 3.518.72± 3.370.0732R-V2(mm)6.42± 2.886.34± 2.807.70± 3.700.0983S-V2(mm)9.78± 4.829.70± 4.7611.02± 5.760.3387R-V3(mm)9.20± 4.409.03± 4.3011.68± 5.140.0348S-V3(mm)5.50± 3.765.41± 3.686.83± 4.790.1872R-V4(mm)13.24± 4.4513.16± 4.4214.38± 4.910.3411S-V4(mm)3.64± 2.943.61± 2.914.21± 3.460.4768R-V5(mm)13.52± 3.9613.45± 3.9814.45± 3.550.3824S-V5(mm)2.53± 2.192.51± 2.162.70± 2.600.7664R-V6(mm)12.09± 3.8012.01± 3.7813.15± 4.080.2956S-V6(mm)1.61± 1.571.62± 1.551.54± 1.870.8512TABLE 10Performance Comparison of Proposed Method and Traditional ECG Voltage Criteria for Female's Test DataSVMCornell voltageSokolow-Lyon voltageCut-off Value0.35520 mm35 mmAccuracy76.4%93.1%91.6%Specificity76.3%99.5%97.4%Sensitivity76.9%0%7.7%Precision18.2%0%16.7%F~1~-score29.4%0%10.5%ROC AUC0.7360.6400.639PR AUC0.1800.1110.089True Negative145189185False Negative31312False Positive4515True Positive1001 FIGURE 6.ROC and PR curves of the proposed method and traditional ECG voltage criteria for the female's test data.

[Fig. 7](#fig7){ref-type="fig"} shows the feature importance with regard to the overall 31 input characteristics. We can see that body height and body weight are the most important factors of echocardiographic LVH with a coefficient magnitude greater than 4 in our SVM model. The other significant predictors of LVH with greater coefficient magnitude include age, heart rate, PR interval, uncorrected QT interval, QRS axis in Lead II, R amplitudes in Lead I, Lead V3, V4, and S amplitudes in Lead V3, V6. FIGURE 7.Feature importance of the 31 input parameters.

C.. Discussion {#sec4c}
--------------

A few studies have utilized machine learning or deep learning techniques for ECG characteristics training to predict the LVH presence [@ref1]--[@ref2][@ref3], [@ref53]--[@ref54][@ref55]. However, the disadvantages are that most of the studies include a small sample size of participants [@ref53]--[@ref54][@ref55], or the output is aimed merely for HCM [@ref2], [@ref3] but not for all kinds of LVH phenotypes in the general population. To our knowledge, the Multi-Ethnic Study of Atherosclerosis (MESA) study might be the only one research in screening for the presence of any unspecific LVH based on the definition of cardiac magnetic resonance imaging in a large sample size of middle and old aged general population [@ref1]. As compared with MESA, our study has superior results as both the ECG characteristics and simple biological features are trained by the SVM. On the basis of feature importance analysis of the proposed SVM model, it is obvious that body height and body weight are the strongest predictors of LVH among young adults. We also notice that an addition of systolic and diastolic blood pressures on the currently used SVM model can improve merely a little or is similar in the detection of LVH. It is reasonable that elevated levels of blood pressure are highly correlated with greater body mass index among young adults [@ref56] and the effect time on cardiac remodeling is relatively short. Therefore, blood pressure may not play a critical role on the development of LVH in young adults.

V.. Conclusion {#sec5}
==============

This study develops a clinically effective ECG-based system with age and simple anthropometric data through the SVM machine learning technique in screening for unspecific LVH among young adults, which improves much in the sum of sensitivity and specificity as compared with the traditional ECG criteria for LVH or using the ECG parameters alone for the machine learning. The sensitivity of our proposed method achieves up to 92.6%. In addition, since the test performances regarding accuracy, specificity, sensitivity, precision, F~1~ score, and the AUCs of the ROC and PR curves for the female samples are not optimal by adopting the SVM model trained by male samples, future studies should be done to clarify the validity of our system operated specifically for young females.
